Becton Dickinson (BDX) just doubled down on immune system science by teaming up with the University of Pennsylvania’s Institute for Immunology and Immune Health to build advanced flow cytometry panels ...

BD (Becton, Dickinson and Company) recently expanded its European infectious disease diagnostics portfolio after IVDR certification of two Certest Biotec VIASURE assays for the fully automated BD MAX™ ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

WASHINGTON, Dec 22 (Reuters) - Becton Dickinson (BDX.N), opens new tab has been sued by a rival medical device manufacturer for allegedly thwarting competition in the U.S. market for surgical hernia ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Entering text into the input field will update the search result below ...

The latest price target for Becton Dickinson (NYSE:BDX) was reported by RBC Capital on December 17, 2025. The analyst firm set a price target for $210.00 expecting BDX to rise to within 12 months (a ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It ...